March 26, 2020 – The U.S. Trade Representative (USTR) announced they are accepting new Section 301 exclusion requests for Chinese origin medical related products, which may be used to combat the COVID-19 virus.
Comments are also being accepted on the new exclusion requests, where you may explain how the product relates to the response to the COVID-19 outbreak, such as whether a product is directly used to treat COVID-19 or limit the outbreak, or if the product is used in the production of needed medical-care products.
Requests and comments may be filed through June 25, 2020, at Regulations.gov, using docket number USTR–2020–0014.
If you have any questions regarding requesting exclusions for Section 301 Chinese origin products, Livingston can help! Please contact either your Livingston account manager or our regulatory affairs department at [email protected]